Your browser doesn't support javascript.
loading
Semaglutide improves treatment satisfaction and eating behaviour in Japanese patients with type 2 diabetes mellitus.
Baba, Yusuke; Watanabe, Suzuka; Hayashi, Saho; Sakai, Toshiki; Naka, Masamitsu; Kami, Saori; Hirayama, Kiichi; Koizumi, Kazuko; Takahashi, Ai; Meguro, Miwako; Iga, Ryo; Yamanaka, Yoshitaka; Kataoka, Masaaki; Uchida, Daigaku; Ishibashi, Ryoichi.
Affiliation
  • Baba Y; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Chiba, Japan.
  • Watanabe S; Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Hayashi S; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Chiba, Japan.
  • Sakai T; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Chiba, Japan.
  • Naka M; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Chiba, Japan.
  • Kami S; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Chiba, Japan.
  • Hirayama K; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Chiba, Japan.
  • Koizumi K; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Chiba, Japan.
  • Takahashi A; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Chiba, Japan.
  • Meguro M; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Chiba, Japan.
  • Iga R; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Chiba, Japan.
  • Yamanaka Y; Department of Rehabilitation, Kimitsu Chuo Hospital, Chiba, Japan.
  • Kataoka M; Department of Surgery, Kimitsu Chuo Hospital, Chiba, Japan.
  • Uchida D; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Chiba, Japan.
  • Ishibashi R; Department of Internal Medicine, Hotaruno Central Naika, Chiba, Japan.
Diabetes Obes Metab ; 26(10): 4787-4790, 2024 Oct.
Article de En | MEDLINE | ID: mdl-39091271
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Satisfaction des patients / Diabète de type 2 / Peptides glucagon-like / Hypoglycémiants Limites: Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Diabetes Obes Metab / Diabetes obes. metab / Diabetes, obesity & metabolism Sujet du journal: ENDOCRINOLOGIA / METABOLISMO Année: 2024 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Satisfaction des patients / Diabète de type 2 / Peptides glucagon-like / Hypoglycémiants Limites: Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Diabetes Obes Metab / Diabetes obes. metab / Diabetes, obesity & metabolism Sujet du journal: ENDOCRINOLOGIA / METABOLISMO Année: 2024 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni